Has Sammy Ho, MD received payments from drug or device companies?

Yes. Drug and device makers reported $194,711 in general payments to Sammy Ho, MD across 566 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sammy Ho, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sammy Ho, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sammy Ho, MD

Gastroenterology · Bronx, NYNPI 1932299765

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (60.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 67.4% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $50,266 and has fallen 57.8% since, to $21,211 in 2025. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$194,711in general payments, 2019–2025

Across 566 payments — averaging $344.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$131K
AbbVie$33K
Olympus America Inc.$15K
Conmed Corporation$4K
Wilson Cook Medical Incorporated$3K
Cook Medical LLC$2K
plus $6K from 25 others

What the payments were for

Consulting fees$32,28417%
Speaking & faculty fees$116,76360%
Travel & lodging$28,24015%
Food & beverage$17,3569%
Gifts$690%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	183	$131,277
AbbVie	73	$33,274
Olympus America Inc.	54	$15,263
Conmed Corporation	35	$3,567
Wilson Cook Medical Incorporated	3	$2,925
Cook Medical LLC	153	$2,054
Merit Medical Systems Inc	4	$1,180
Pentax Of America, Inc.	3	$811
Olympus Corporation	3	$798
US Endoscopy	1	$550
Micro-tech Endoscopy USA, Inc.	7	$549
Olympus Latin America, Inc.	2	$368
Takeda Pharmaceuticals U.S.A., Inc.	13	$297
Steris Corporation	2	$260
Fujifilm Healthcare Americas Corporation	6	$199
Olympus Corporation Of The Americas	2	$194
Creo Medical Inc.	2	$181
Endogastric Solutions, Inc	1	$144
Medtronic	1	$126
Covidien LP	2	$121
Exact Sciences	2	$117
Laborie Medical Technologies Corp.	1	$90
Vivus LLC	3	$85
Baxter Healthcare	1	$78
Celltrion USA Inc.	2	$62
Johnson & Johnson	1	$38
Ambu Inc.	2	$36
Amgen	1	$21
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$20
Novo Nordisk	1	$14
Apollo Endosurgery US Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$42,921
EXALT Model D$31,639
SPYGLASS$20,057
Creon$16,751
Olympus EUS Devices$6,619
Olympus Biliary Devices$6,079
Olympus EndoTherapy Accessories$5,919
VISIGLIDE$4,049
Cook Medical Hemospray$3,263
EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE$2,170
EVIS EUS ENDOSCOPIC ULTRASOUND CENTER$1,803
GORE VIABIL$1,800
BEAMER SYSTEM$1,800
HEMOSTASIS CLIP$1,800
EXPECT$1,770
GENERAL PAIN MANAGEMENT$1,322
CONMED BILIARY$943
GENERAL - BILIARY DEVICES$880
Transmaxx$700
AXIOS$680

How this compares

$194,711 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024

$164,629

Medicare patients

379

Services billed

714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	153	$2,193
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl	36	$487
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	24	$363

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Bronx

David SteinBronx$196K
Vivek GumasteBronx$139K
David Carr LockeNew York$2M
Arthur KornbluthNew York$1.9M
Maya SrivastavaWilliamsville$1.8M
Melissa PalmerPlainview$1M
Sonal KumarNew York$1M
David PoppersNew York$939K
Ellen ScherlNew York$857K
Bruce SandsNew York$810K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →